找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?; Van Anh Le Book 2022 The Editor(s) (if ap

[复制链接]
楼主: genial
发表于 2025-3-25 05:22:38 | 显示全部楼层
发表于 2025-3-25 07:56:35 | 显示全部楼层
发表于 2025-3-25 13:32:04 | 显示全部楼层
发表于 2025-3-25 18:58:41 | 显示全部楼层
The Development of Compulsory Licensing in International Patent Laws, Doha Declaration which clarifies Article 31. A significant attention will be paid to Article 31 because it sets out the procedure to issue a compulsory licence. As seen in Chapter . how the patent system has considerably changed from Paris to TRIPS, this chapter also reveals a paradigm shift in the compulsory licensing regime.
发表于 2025-3-25 21:19:23 | 显示全部楼层
发表于 2025-3-26 02:50:17 | 显示全部楼层
发表于 2025-3-26 06:11:46 | 显示全部楼层
发表于 2025-3-26 09:09:11 | 显示全部楼层
The Bilingualism Controversy: Les Préludes Doha Declaration which clarifies Article 31. A significant attention will be paid to Article 31 because it sets out the procedure to issue a compulsory licence. As seen in Chapter . how the patent system has considerably changed from Paris to TRIPS, this chapter also reveals a paradigm shift in the
发表于 2025-3-26 14:11:24 | 显示全部楼层
https://doi.org/10.1007/978-3-531-91596-8n Patent Controller, for the first time, granted a compulsory licence to Natco, a domestic generic firm, to manufacture Nexavar, a patented medicine owned by Bayer. While this historic decision seemed to herald a new era of compulsory licensing in the region, the Controller, unexpectedly, turned dow
发表于 2025-3-26 19:14:38 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-22 09:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表